Showing results (61-70 of 104) with videos related to
Sort By:
Pageof 11
American Journal of Medical Genetics. Part A|September 13, 2011
FGFR3 related skeletal dysplasias diagnosed prenatally by ultrasonography and molecular analysis: presentation of 17 casesAngeliki Hatzaki, Stavros Sifakis, Despina Apostolopoulou, et al.Nature Chemistry|November 24, 2012
A flow-system array for the discovery and scale up of inorganic clustersCraig J Richmond, Haralampos N Miras, Andreu Ruiz de la Oliva, et al.Neoplasia (New York, N.Y.)|September 12, 2022
Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressivenessChaido Sirinian, Anastasios D Papanastasiou, Ozge Karayel, et al.Cancer Chemotherapy and Pharmacology|September 29, 2007
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group studyE Briasoulis, G Fountzilas, A Bamias, et al.Cancers|April 11, 2020
Differentially Methylated Ultra-Conserved Regions Uc160 and Uc283 in Adenomas and Adenocarcinomas Are Associated with Overall Survival of Colorectal Cancer PatientsAnastasia E Kottorou, Foteinos-Ioannis D Dimitrakopoulos, Anna G Antonacopoulou, et al.Anti-Cancer Drugs|January 19, 2005
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use programE Razis, D Skarlos, E Briasoulis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2007
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology GroupP A Kosmidis, H P Kalofonos, C Christodoulou, et al.Scientific Reports|October 6, 2019
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC PatientsFoteinos-Ioannis D Dimitrakopoulos, Anna G Antonacopoulou, Anastasia E Kottorou, et al.BMC Cancer|May 31, 2013
Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational studyEvangelos Briasoulis, Gerasimos Aravantinos, George Kouvatseas, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) StudyA Psyrri, K T Kalogeras, R Kronenwett, et al.Pageof 11